On September 21, 2016, Gradocell attended the press conference at the Puerta de Hierro Hospital on the presentation of the results of the Clinical Trial for the treatment of chronic complete paraplegia using cell therapy, led by the team of Dr. Jesús Vaquero.
Gradocell implemented GMP standards in the Neuroscience Cell Manufacturing Unit (UINC) between 2010 and 2012, which resulted in obtaining a GMP certificate issued by AEMPS in 2012.
